Brief: Mankind Pharma Q3 Consol Net Profit 3.8 Bln Rupees
23/01/2025 13:46
Jan 23 (Reuters) - Mankind Pharma Ltd MNKI.NS :
* Q3 CONSOL NET PROFIT 3.8 BILLION RUPEES; IBES PROFIT EST.
4.48
BILLION RUPEES
* Q3 CONSOL REVENUE FROM OPERATIONS 32.3 BILLION RUPEES;
IBES EST.
32.28 BILLION RUPEES
Source text: ID:
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery